DK1165102T3 - Matrixproteinpræparater til podning i ikke-mineraliseret væv - Google Patents
Matrixproteinpræparater til podning i ikke-mineraliseret vævInfo
- Publication number
- DK1165102T3 DK1165102T3 DK00906554T DK00906554T DK1165102T3 DK 1165102 T3 DK1165102 T3 DK 1165102T3 DK 00906554 T DK00906554 T DK 00906554T DK 00906554 T DK00906554 T DK 00906554T DK 1165102 T3 DK1165102 T3 DK 1165102T3
- Authority
- DK
- Denmark
- Prior art keywords
- grafting
- matrix protein
- protein preparations
- mineralized tissue
- enamel matrix
- Prior art date
Links
- 238000002360 preparation method Methods 0.000 title abstract 2
- 108060003393 Granulin Proteins 0.000 title 1
- 210000003298 dental enamel Anatomy 0.000 abstract 2
- 239000011159 matrix material Substances 0.000 abstract 2
- 102100040409 Ameloblastin Human genes 0.000 abstract 1
- 210000000988 bone and bone Anatomy 0.000 abstract 1
- 108010074702 enamel matrix proteins Proteins 0.000 abstract 1
- 210000004877 mucosa Anatomy 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000001737 promoting effect Effects 0.000 abstract 1
- 210000004872 soft tissue Anatomy 0.000 abstract 1
- 210000001519 tissue Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/1703—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- A61K38/1709—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/12—Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
- A61K35/32—Bones; Osteocytes; Osteoblasts; Tendons; Tenocytes; Teeth; Odontoblasts; Cartilage; Chondrocytes; Synovial membrane
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/02—Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P17/00—Drugs for dermatological disorders
- A61P17/14—Drugs for dermatological disorders for baldness or alopecia
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/04—Drugs for skeletal disorders for non-specific disorders of the connective tissue
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P27/00—Drugs for disorders of the senses
- A61P27/02—Ophthalmic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P41/00—Drugs used in surgical methods, e.g. surgery adjuvants for preventing adhesion or for vitreum substitution
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Engineering & Computer Science (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Medicinal Chemistry (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Zoology (AREA)
- Dermatology (AREA)
- Biomedical Technology (AREA)
- Physical Education & Sports Medicine (AREA)
- Epidemiology (AREA)
- Immunology (AREA)
- Developmental Biology & Embryology (AREA)
- Ophthalmology & Optometry (AREA)
- Surgery (AREA)
- Orthopedic Medicine & Surgery (AREA)
- Rheumatology (AREA)
- Marine Sciences & Fisheries (AREA)
- Biotechnology (AREA)
- Cell Biology (AREA)
- Gastroenterology & Hepatology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Virology (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Cosmetics (AREA)
- Medicinal Preparation (AREA)
- Peptides Or Proteins (AREA)
- Graft Or Block Polymers (AREA)
- Materials For Medical Uses (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| DKPA199900337 | 1999-03-10 | ||
| PCT/IB2000/000247 WO2000053197A1 (en) | 1999-03-10 | 2000-03-09 | Matrix protein compositions for grafting |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK1165102T3 true DK1165102T3 (da) | 2004-06-01 |
Family
ID=8092401
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK00906554T DK1165102T3 (da) | 1999-03-10 | 2000-03-09 | Matrixproteinpræparater til podning i ikke-mineraliseret væv |
Country Status (8)
| Country | Link |
|---|---|
| EP (1) | EP1165102B1 (da) |
| JP (1) | JP4726300B2 (da) |
| AT (1) | ATE258442T1 (da) |
| AU (1) | AU2821200A (da) |
| DE (1) | DE60007973T2 (da) |
| DK (1) | DK1165102T3 (da) |
| ES (1) | ES2215028T3 (da) |
| WO (1) | WO2000053197A1 (da) |
Families Citing this family (10)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE60140191D1 (de) * | 2000-06-20 | 2009-11-26 | Straumann Inst Ag | Zusammensetzungen mit matrixproteinen zur regeneration von dentin |
| US7033611B2 (en) | 2001-02-23 | 2006-04-25 | Biora Bioex Ab | Matrix protein compositions for guided connective tissue growth |
| CA2438084C (en) * | 2001-02-23 | 2011-02-15 | Biora Bioex Ab | Matrix protein compositions for guided connective tissue growth |
| JP2004307454A (ja) | 2003-02-21 | 2004-11-04 | Seikagaku Kogyo Co Ltd | 生理活性ペプチド及びこれを含有する薬剤 |
| EP2329832A1 (en) | 2004-12-10 | 2011-06-08 | Straumann Holding AG | Protein formulation |
| WO2011051457A2 (en) | 2009-11-02 | 2011-05-05 | Straumann Holding Ag | Purified emd protein composition |
| WO2011073447A1 (en) | 2009-12-18 | 2011-06-23 | Straumann Holding Ag | Emd c-depleted |
| US9789190B2 (en) | 2010-10-15 | 2017-10-17 | Straumann Holding Ag | EMD formulation comprising PGA |
| US9957314B2 (en) | 2011-05-09 | 2018-05-01 | Hadasit Medical Research Services And Development Ltd. | Regeneration and repair of mesenchymal tissue using amelogenin |
| ES2708976T3 (es) * | 2014-01-17 | 2019-04-12 | Straumann Holding Ag | Procedimiento para producir EMD de estabilidad aumentada |
Family Cites Families (3)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4672032A (en) * | 1983-11-09 | 1987-06-09 | University Of Southern California | Dental enamel production |
| SE454480B (sv) * | 1986-09-25 | 1988-05-09 | Lars Hammarstrom | Bindningsinducerande komposition |
| SE461313B (sv) * | 1988-03-17 | 1990-02-05 | Biora Ab | Bindningsinducerande komposition |
-
2000
- 2000-03-09 EP EP00906554A patent/EP1165102B1/en not_active Expired - Lifetime
- 2000-03-09 ES ES00906554T patent/ES2215028T3/es not_active Expired - Lifetime
- 2000-03-09 DK DK00906554T patent/DK1165102T3/da active
- 2000-03-09 JP JP2000603686A patent/JP4726300B2/ja not_active Expired - Fee Related
- 2000-03-09 WO PCT/IB2000/000247 patent/WO2000053197A1/en not_active Ceased
- 2000-03-09 DE DE60007973T patent/DE60007973T2/de not_active Expired - Lifetime
- 2000-03-09 AU AU28212/00A patent/AU2821200A/en not_active Abandoned
- 2000-03-09 AT AT00906554T patent/ATE258442T1/de not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| JP4726300B2 (ja) | 2011-07-20 |
| DE60007973T2 (de) | 2004-12-23 |
| ATE258442T1 (de) | 2004-02-15 |
| DE60007973D1 (de) | 2004-03-04 |
| ES2215028T3 (es) | 2004-10-01 |
| EP1165102A1 (en) | 2002-01-02 |
| AU2821200A (en) | 2000-09-28 |
| JP2002538212A (ja) | 2002-11-12 |
| EP1165102B1 (en) | 2004-01-28 |
| WO2000053197A1 (en) | 2000-09-14 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| WO2003064449A3 (en) | Bioactive keratin peptides | |
| WO1998033509A3 (en) | Useful properties of human lactoferrin and variants thereof | |
| EP1196444B8 (en) | Exendin-4 conjugates and their medical use | |
| TR199802423T2 (xx) | Konsantre antikor terkibi. | |
| MXPA02006679A (es) | Composicion farmaceutica. | |
| NO20045521L (no) | Diarylureaderivater anvendelige for behandling av proteinkinaseavhengige sykdommer | |
| DE50004018D1 (de) | Verwendung natriuretischer peptide als antibiotisch wirksame substanzen zur behandlung von bakteriellen infektionen | |
| AR020055A1 (es) | Una composicion farmaceutica o cosmetica que contiene una sustancia de esmalte activa, usos de dicha composicion y un metodo para preparar la misma. | |
| BR9406720A (pt) | Utilização de um adenovírus recombinante de origem animal adenovírus recombinante de origem animal e composição farmacêutica compreendendo um ou vários adenovírus | |
| NO20022599L (no) | Klorofyll- og bakterioklorofyllestere, deres fremstilling og farmasöytiske sammensetninger som innbefatter slike | |
| TR200100054T2 (tr) | Paroksetin metansülfonat | |
| ATE198050T1 (de) | Therapeutische anwendungen von bpi-protein- produkten zur behandlung von humaner meningococcämia | |
| TR199802534T2 (xx) | Leptin (OB Protein) fragmanlar� | |
| DK1059934T3 (da) | Matrixproteinpræparater til sårheling | |
| HK1045816A1 (zh) | 角质细胞生长因子-2制剂 | |
| EP0797999A3 (en) | Formulations of obesity protein | |
| DK0482097T3 (da) | Tensidpræparater og fremgangsmåder | |
| DK1165102T3 (da) | Matrixproteinpræparater til podning i ikke-mineraliseret væv | |
| TW374085B (en) | Novel piperidine derivatives, their preparation, pharmaceutical formulation and medical use | |
| DE69831223D1 (de) | Gefriergetrocknete zusammensetzung des menschlichen,morphogenen knochenproteins mp52 | |
| EP1038958A4 (en) | HUMAN NAP1 PROTEIN | |
| PT1124577E (pt) | Utilizacao de uma proteina ompa de enterobacteria para o direccionamento especifico para as celulas apresentadoras de antigenios | |
| EP0821969A3 (en) | Medicinal Composition comprising TCF-II | |
| DE69816808D1 (de) | Somatostatin agoniste zur reduzierung von körpergewicht | |
| BG103905A (en) | New bpc peptide salts with organoprotective activity, method for their preparation and application in medicine |